CANCEL STEM: Cancer cell staminality: A challenge and an opportunity to advance treatment in Oncology (Q2905919): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 2,040,532.09 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 1,734,452.28 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
85.0 percent
| |||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 11:28, 5 November 2022
Project Q2905919 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CANCEL STEM: Cancer cell staminality: A challenge and an opportunity to advance treatment in Oncology |
Project Q2905919 in Portugal |
Statements
1,734,452.28 Euro
0 references
2,040,532.09 Euro
0 references
85.0 percent
0 references
1 January 2017
0 references
31 March 2021
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016390
0 references